Literature DB >> 7225273

Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics.

N R Davis, W W Mapleson.   

Abstract

Mapleson's (1973) physiological, circulation-time model of the distribution of inhaled anaesthetics has been elaborated to be suitable for modelling agents in which hepatic metabolism and renal excretion are important factors; as well as the obvious improvement of providing separate compartments for liver and kidney, the arterial and portal supplies to the liver are separately represented, as is the portal blood pool. The separate portal pool also leads to a more realistic total circulation time for the majority of the cardiac output. The quantification for a "standard man" is fully documented and makes use of the latest (1975) report of the International Commission on Radiological Protection, Reference Man, and includes data on the water, fat and protein composition of each tissue compartment. Suggestions are included on adapting the quantification to non-standard men and to other species.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225273     DOI: 10.1093/bja/53.4.399

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

1.  On the formalization of multi-scale and multi-science processes for integrative biology.

Authors:  Vanessa Díaz-Zuccarini; César Pichardo-Almarza
Journal:  Interface Focus       Date:  2011-03-30       Impact factor: 3.906

2.  A simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent vapours.

Authors:  A Sato; K Endoh; T Kaneko; G Johanson
Journal:  Br J Ind Med       Date:  1991-05

Review 3.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

4.  Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man.

Authors:  A Koizumi
Journal:  Br J Ind Med       Date:  1989-04

5.  Confounding factors in biological monitoring of exposure to organic solvents.

Authors:  A Sato
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

6.  A physiologically based mathematical model for the human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane.

Authors:  T R Auton; B H Woollen
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

7.  A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man.

Authors:  G A Csanády; A L Mendrala; R J Nolan; J G Filser
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

8.  A physiologically based pharmacokinetic model for nicotine and cotinine in man.

Authors:  D E Robinson; N J Balter; S L Schwartz
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

9.  PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.

Authors:  David G Levitt
Journal:  BMC Anesthesiol       Date:  2002-08-15       Impact factor: 2.217

10.  A dynamic model of the body gas stores for carbon dioxide, oxygen, and inert gases that incorporates circulatory transport delays to and from the lung.

Authors:  Snapper R M Magor-Elliott; Christopher J Fullerton; Graham Richmond; Grant A D Ritchie; Peter A Robbins
Journal:  J Appl Physiol (1985)       Date:  2021-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.